Filter
689
Filtered Results: 689
Text search:
insulina
Featured
Recommendations
89
New Publications
216
Language
Document type
No document type
334
Guidelines
156
Studies & Reports
112
Manuals
36
Fact sheets
18
Strategic & Response Plan
12
Infographics
10
Training Material
5
Resource Platforms
3
Brochures
2
Videos
1
Countries / Regions
Global
69
India
40
Latin America and the Carribbean
20
Ethiopia
19
Kenya
17
South Africa
16
Paraguay
15
Philippines
12
Bangladesh
12
Indonesia
12
Nepal
11
Rwanda
10
Venezuela
10
Germany
10
Western and Central Europe
10
Tanzania
9
Congo, Democratic Republic of
9
Uganda
9
Chile
8
Syria
8
Malawi
8
North America
8
Argentina
8
Namibia
8
Ukraine
7
Haiti
7
Nigeria
6
Mozambique
6
South–East Asia Region
6
Bolivia
6
Brazil
6
Ghana
5
Sierra Leone
5
Senegal
5
Peru
5
Africa
5
Zambia
5
Burkina Faso
4
Guinea
4
Asia
4
Eastern Europe and Central Asia
4
Liberia
4
Eswatini/ Swaziland
4
Lesotho
3
Zimbabwe
3
Colombia
2
Cambodia
2
Côte d’Ivoire / Ivory Coast
2
Chad
2
Botswana
2
Myanmar / Burma
2
Tajikistan
1
Turkey
1
Benin
1
Kazakhstan
1
Cameroon
1
Fiji
1
USA
1
Guinea-Bissau
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Jamaica
1
United Kingdom
1
Spain
1
Azerbaijan
1
East and Southern Africa
1
Latvia
1
Eastern Europe
1
Moldova
1
Russia
1
Central African Republic
1
Mali
1
Angola
1
Libya
1
Bhutan
1
South Sudan
1
Somalia
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
314
Clinical Guidelines
104
Public Health
101
Women & Child Health
23
Capacity Building
9
Key Resources
7
Pharmacy & Technologies
6
Toolboxes
NCDs
102
Pharmacy
55
Mental Health
39
COVID-19
30
Refugee
28
Caregiver
23
Conflict
20
HIV
16
TB
16
Planetary Health
10
Ebola
9
Disability
7
Global Health Education
7
NTDs
6
AMR
6
Rapid Response
5
Natural Hazards
3
Health Financing Toolbox
3
Polio
2
Health Financing
1
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage
to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Diabetes mellitus (DM) is a global epidemic with significant morbidity. Diabetic
retinopathy (DR) is the specific microvascular complication of DM and affects 1 in 3 persons with DM. DR remains a leading cause of vision loss in working adult populations. Patients with severe levels of DR are report...
This report includes six case studies from 12 individuals with lived experience of diverse health conditions. These case studies explore the topics of power dynamics and power reorientation towards individuals with lived experience; informed decision-making and health literacy; community engagement ...
Il s’agit du premier rapport d’une collection de l’OMS intitulée De l’intention à l’action, qui vise à renforcer la base de données probantes sur l’impact de la participation significative et à combler le manque d’approches normalisées pour permettre la participation significativ...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
This guideline provides evidence-informed guidance on the use of non-sugar sweeteners to reduce the risk of unhealthy weight gain and diet-related noncommunicable diseases in adults and children. The guidance in this guideline is not based on toxicological assessments of the safety of individual no...
Small island developing states (SIDS) are a set of islands and coastal states that share similar sustainable development challenges, as a result of their size, geography and vulnerability to climate change. Thirty-nine WHO member states in four regions – the African Region, the Region of the Ameri...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
The standards define 10 key competencies for health and care workers to support self-care in their clinical practice as well as the specific, measurable behaviours that demonstrate those competencies, focusing on people-centredness; decision-making; effective communication; collaboration; evidence-i...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
The thirty-seventh meeting of the Programme, Budget and Administration Committee was held in Geneva from 25 to 27 January 2023 and chaired by Ms Aishath Rishmee (Maldives). The Committee adopted its agenda and agreed its programme of work. In his opening remarks, the Director-General emphasized the ...
Les médicaments ont été classés à la fois par classe pharmaco-thérapeutique et par ordre alphabétique. La présence d’une marque astérisque renvoie à davantage de précision pour le (les) médicament(s) concerné(s).
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
The International Rescue Committee (IRC) is a leading humanitarian agency dedicated to helping people whose lives have been shattered by conflict and disaster to survive, recover, and gain control of their future. Health comprises nearly half of IRC’s program portfolio globally and encompasses thr...
Global progress against cardiovascular disease (CVD) is flatlining.
Though rates of CVD deaths globally have fallen in the last three
decades, this trend has begun to stall and, without concerted
efforts, is at risk of reversing.
Background
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.
Methods
This review is based on articles retrieved by a selective search in PubMed, as well as on r...
